Epstein-barr Virus Current Events | Epstein-barr Virus News
|
| Page
1 of
49 |
965 Results |
|
|
|
Sort By:
Page Views | Date |
Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
Endemic Burkitt lymphoma is a form of cancer that accounts for up to 74% of malignant disorders in children in equatorial Africa. Malaria and Epstein-Barr virus (EBV) are known cofactors in its development, but to date, their relative contribution has not been well understood. view more (2007-06-08)
Epstein-Barr virus may be associated with multiple sclerosis
Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later. view more (2006-04-11)
OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus. view more (2008-11-11)
Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection. view more (2009-11-03)
Hit-and-run injury to the brain
A seven-year tracking study has prompted scientists to suggest that chronic fatigue syndrome could be the result of brain injuries inflicted during the early stages of glandular fever. view more (2006-03-02)
U of T researchers reveal Epstein-Barr virus protein contributes to cancer
Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development. view more (2008-10-07)
Rare head and neck cancer linked to HPV, study finds
An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-10-08)
Mechanism for Epstein-Barr virus protein's role in blood cancers discovered
Earlier this year, researchers at the University of Pennsylvania School of Medicine identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers. view more (2005-12-27)
A double-barreled immune cell approach for neuroblastoma
Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells' ability to fight a form of childhood cancer called neuroblastoma, said researchers form Baylor College of Medicine and Texas Children's Hospital in a report that appears online today in the... view more... (2008-11-03)
Waking a sleeping virus
A detailed structural picture of a molecule that plays a key role in activating the Epstein Barr Virus in human cells has now been obtained by researchers at the European Molecular Biology Laboratory (EMBL) and the Institut de Virologie Moléculaire et Structurale (IVMS), associated with the Université Joseph Fourier and the... view more... (2006-02-17)
New lab mice pave way for novel studies of human infection
A new type of laboratory mouse developed at UT Southwestern Medical Center can fight certain infections the same way humans do, making the rodents very useful for novel studies of human-pathogen interaction and developing disease therapies. view more (2006-10-23)
Epstein-Barr Virus Might Kick-Start Multiple Sclerosis
Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus. view more (2006-05-02)
Clue found to Epstein-Barr virus' ability to form and sustain tumors
Researchers at the University of Wisconsin School of Medicine and Public Health (SMPH) have found a viral target that opens the door for the development of drugs to destroy tumors caused by Epstein-Barr virus (EBV). view more (2006-09-06)
Epstein-Barr: a virtual look at a vexing virus
Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans. view more (2007-10-23)
Herpes viruses hedge their bets: latency boosts survival
Herpes viruses have two infectious phases: one just after infecting a new host, and one years or decades later when they reactivate. view more (2002-10-31)
Chronic fatigue syndrome linked to stomach virus
Chronic fatigue syndrome, also known as ME (myalgic encephalitis), is linked to a stomach virus, suggests research published ahead of print in Journal of Clinical Pathology. view more (2007-09-14)
Researchers have discovered a gene that can block the spread of HIV
A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS. view more (2008-02-29)
Signal molecule holds possible key to tumour growth
Immunity to a cancer in chickens could shed light on ways to control certain human cancers according to scientists from the Institute for Animal Health (IAH). Their work on Marek's disease (MD) in chickens has identified the first natural model for specific Hodgkin's and non-Hodgkin's lymphomas, and is published this week in PNAS (06-10 September... view more... (2004-09-06)
Innovative method for creating a human cytomegalovirus vaccine outlined
Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour. view more (2006-08-01)
'Killer' cells used to combat rare cancer
Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer which can affect transplant patients. And their findings, published recently in The Lancet show that the therapy has proved effective in a number of cases. The treatment proved successful last year in saving the life of a... view more... (2002-09-10)
|
|
| Page
1 of
49 |
965 Results |
|
|
|
Sort By:
Page Views | Date |
|
